Advertisement
Canada markets close in 2 hours 42 minutes
  • S&P/TSX

    22,165.33
    +58.25 (+0.26%)
     
  • S&P 500

    5,249.85
    +1.36 (+0.03%)
     
  • DOW

    39,756.56
    -3.52 (-0.01%)
     
  • CAD/USD

    0.7387
    +0.0014 (+0.19%)
     
  • CRUDE OIL

    82.83
    +1.48 (+1.82%)
     
  • Bitcoin CAD

    95,569.88
    +1,724.35 (+1.84%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,243.00
    +30.30 (+1.37%)
     
  • RUSSELL 2000

    2,126.70
    +12.35 (+0.58%)
     
  • 10-Yr Bond

    4.1980
    +0.0020 (+0.05%)
     
  • NASDAQ

    16,369.90
    -29.62 (-0.18%)
     
  • VOLATILITY

    12.98
    +0.20 (+1.56%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6838
    +0.0033 (+0.49%)
     

Investing in cannabis is 'a great hedge' for alcohol and drug companies, Tilray CEO says

Tilray CEO Brendan Kennedy shares his take on the future of medical and recreational marijuana with CNBC's Jim Cramer. Kennedy tells the "Mad Money" host that drug and alcohol makers should turn their focus to companies like his. Pharmaceutical companies have to start thinking about partnering with cannabis companies as a "hedge" against the burgeoning marijuana industry, Tilray TLRY CEO Brendan Kennedy told CNBC on Tuesday.